<table border="0" cellpadding="0" cellspacing="0" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 9: Established Drug Interactions with Didanosine 
			</caption>
<col></col>
<col></col>
<col></col>
<thead>
<tr>
<th stylecode="Lrule Rrule Toprule">Drug </th>
<th stylecode="Lrule Rrule Toprule">Effect </th>
<th stylecode="Lrule Rrule Toprule">Clinical Comment </th>
</tr>
</thead>
<tfoot>
<tr>
<td colspan="3">↑ Indicates increase. <br/>↓ Indicates decrease. <br/>
<sup>a</sup> The dosing recommendation for coadministration of didanosine delayed-release capsules and tenofovir disoproxil fumarate with respect to meal consumption differs from that of didanosine. See the complete prescribing information for didanosine delayed-release capsules. <br/>
</td>
</tr>
</tfoot>
<tbody>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">   ciprofloxacin <br/>
</td>
<td stylecode="Rrule" valign="top">   ↓ ciprofloxacin<br/>   concentration<br/>
</td>
<td stylecode="Rrule" valign="top">Administer didanosine at least 2 hours after or 6 hours before ciprofloxacin. <br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">   delavirdine <br/>
</td>
<td stylecode="Rrule" valign="top">   ↓ delavirdine<br/>   concentration <br/>
</td>
<td stylecode="Rrule" valign="top">Administer didanosine 1 hour after delavirdine. <br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">   ganciclovir <br/>
</td>
<td stylecode="Rrule" valign="top">   ↓ didanosine<br/>   concentration<br/>
</td>
<td stylecode="Rrule" valign="top">If there is no suitable alternative to ganciclovir, then use in combination with didanosine with caution. Monitor for didanosine-associated toxicity. <br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">   indinavir <br/>
</td>
<td stylecode="Rrule" valign="top">   ↓ indinavir<br/>   concentration<br/>
</td>
<td stylecode="Rrule" valign="top">Administer didanosine 1 hour after indinavir. <br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">   methadone <br/>
</td>
<td stylecode="Rrule" valign="top">   ↓ didanosine<br/>   concentration<br/>
</td>
<td stylecode="Rrule" valign="top">Do not coadminister methadone with didanosine pediatric powder due to significant decreases in didanosine concentrations. If coadministration of methadone and didanosine is necessary, the recommended formulation of didanosine is didanosine delayed-release capsules. Patients should be closely monitored for adequate clinical response when didanosine delayed-release capsules are coadministered with methadone, including monitoring for changes in HIV RNA viral load.<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">   nelfinavir<br/>
</td>
<td stylecode="Rrule" valign="top">   ↓ No interacion<br/>   1 hour after<br/>   didanosine<br/>
</td>
<td stylecode="Rrule" valign="top">Administer nelfinavir 1 hour after didanosine.<br/>
</td>
</tr>
<tr>
<td stylecode="Lrule Rrule" valign="top">   tenofovir <br/>disoproxil <br/>   fumarate<br/>
</td>
<td stylecode="Rrule" valign="top">   ↓ didanosine<br/>   concentration<br/>
</td>
<td stylecode="Rrule" valign="top">A dose reduction of didanosine to the following dosage once daily is recommended.<sup>a</sup>
<br/>
<list listtype="unordered" stylecode="Disc">
<item>250 mg (adults weighing at least 60 kg with creatinine clearance of at least 60 mL/min)                </item>
<item>200 mg (adults weighing less than 60 kg with creatinine clearance of at least 60 mL/min) </item>
</list>Didanosine and tenofovir disoproxil fumarate may be taken together in the fasted state. If tenofovir disoproxil fumarate is taken with food, didanosine should be taken on an empty stomach (at least 30 minutes before food or 2 hours after food). Patients should be monitored for didanosine­-associated toxicities and clinical response.<br/>
</td>
</tr>
</tbody>
</table>